INS and type 2 diabetes mellitus: Although an insufficient β cell mass is essential for the development of T2DM [17], it is difficult to accurately measure β cell mass in living people, and insulin secretion capacities widely vary; therefore, β cell mass has limited use as a biomarker for new onset diabetes.